Facebook Twitter LinkedIn Instagram Email Printer Google Plus

Future Market

Five Healthcare Predictions from Sam Glick and Terry Stone

2020 was a transformative year. Here's what might happen next with COVID-19, pharmacy cost, telehealth, and more.

Partner, Health and Life Sciences, Oliver Wyman
Managing Partner, Health and Life Sciences, and Global Chair for I&D, Oliver Wyman

Future Truths: Inevitable and Inspiring

Harnessing genomics will transform our daily lives, disrupt payer, provider, and pharma business models, and create new markets for next-generation prevention.

Partner, Health and Life Sciences, Oliver Wyman
Partner, Health and Life Sciences, Oliver Wyman
Principal, Oliver Wyman
Associate, Health and Life Sciences, Oliver Wyman

How to leverage voice-enabled digital physician assistants to address clinical documentation burden and physician burnout.

Founder and CEO, Suki
Partner, Health & Life Sciences, Oliver Wyman

Why closing the loop and creating a virtuous health promotion cycle will transform "sick care" to "well-care."

Partner, Health and Life Sciences, Oliver Wyman
Associate, Oliver Wyman

Future Truths: Inevitable and Inspiring

The financial services industry lays out a path for what data sharing's evolution in healthcare could look like.

President, CareJourney
Partner, Financial Services, Oliver Wyman
Partner, Health & Life Sciences, Oliver Wyman
Former Principal, Health and Life Sciences, Oliver Wyman

Insights in your inbox

Subscribe

Six Predictions for an Industry in Transformation

Welltok and Oliver Wyman discuss why this year is healthcare's watershed moment and what may unfold in 2021.

Chairman of the Board, Welltok
Partner, Health and Life Sciences, Oliver Wyman

Success awaits innovators that leverage pharma in a newly digitized world.

Partner, Health and Life Sciences, Oliver Wyman
Principal, Health and Life Sciences, Oliver Wyman

Even with drastically increased investment and adoption, we're still early in telemedicine’s trajectory.

Founder and CEO, Virta Health

To what extent is COVID-19 a catalyst for sustained employer change? And what should stakeholders be focused on next?

President and CEO, Business Group on Health
Partner, Health & Life Sciences, Oliver Wyman

A discussion on telemedicine's progress and newly emerging physician opportunities.

Chief Clinical Officer, Privia Health
Partner, Health & Life Sciences, Oliver Wyman

Insights in your inbox

Subscribe